1. Arteaga CL. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J Clin Oncol 2001; 19: 32s–40s.
2. Atlas I, Mendelsohn J, Baselga J, Fair WR, Masui H, Kumar R. Growth regulation of human renal carcinoma cells: role of transforming growth factor α. Cancer Res 1992; 52: 3335–9.
3. Auerbach W, Auerbach R. Angiogenesis inhibition: a review. Pharmacol Ther 1994; 63: 265–311.
4. Augustin HG, Kmeta J, Alves F, et al. Quantitating angiogenesis and assessing the causal relationship between angiogenesis and tumorigenesis: problems and progress. Ann Hematol 2002; 81(Suppl 2): 68–72.
5. Baker CH, Fidler IJ. Tumor microenvironment and angiogenesis. In: Davis DW, Herbst RS, Abbruzzese JL, eds. Antiangiogenic cancer therapy. Boca Raton, FL: CRC Press, 2008: 131–47.